Información de perfil
Francisco J. Fernandez received his PhD from the European Molecular Biology Laboratory (EMBL) and the Autonomous University of Barcelona (UAB), and carried out his postgraduate studies at the Dutch National Cancer Institute (NKI) and at the EMBL Hamburg Outstation (EMBL HH). In 2004 he returned to Spain to work as a senior postdoctoral researcher at the Spanish National Research Council (CSIC). He has over fifteen years of experience in structural biology and nearly a decade-long track record in developing, patenting and publishing novel platform technologies. Francisco is co-founder and the CEO of Abvance, and provides scientific leadership to the antibody drug discovery, business strategy and partnering programmes.